#USA #Jupiter #Amar'e Stoudemire #NOVODX #GoldN Reader

NBA Star Amar'e Stoudemire Joins NOVODX Advisory Board

In an exciting announcement, NOVODX Corporation, a leader in next-generation at-home and point-of-care lab testing, has welcomed six-time NBA All-Star Amar'e Stoudemire to its Advisory Board. This partnership is set to accelerate NOVODX's mission of making reliable and affordable preventive healthcare more accessible to everyone.

About NOVODX and Its Innovations

NOVODX is paving the way in health technology with its flagship product, the GoldN Reader—a portable at-home testing platform designed for delivering rapid test results within 15 minutes. This revolutionary device aims to eliminate the need for shipping samples to a laboratory, making healthcare immediate and efficient.

The GoldN Reader is intended to support a diverse range of tests that cover women’s health, fertility, infectious diseases, oncology, micronutrient analysis, and preventive screenings. By providing access to timely health information, NOVODX seeks to enhance the early detection of health issues and facilitate proactive personal health management.

Amar'e Stoudemire's Role and Vision

For Amar'e Stoudemire, joining NOVODX is not just a professional endeavor but a personal commitment to wellness. He stated, “Access to reliable, timely health information changes lives. I’m proud to join NOVODX in bringing powerful tools like the GoldN Reader into communities everywhere, so people can take control of their health before problems become critical.”

Stoudemire, who is celebrated for his remarkable career with the Phoenix Suns, New York Knicks, and Miami Heat, has a broad business portfolio that spans sports, wellness, and philanthropy. His alignment with NOVODX’s focus on empowering individuals to manage their health aligns perfectly with their innovative solutions.

Leadership's Vision for Health Equity

Nancy Torres, CEO of NOVODX, expressed her enthusiasm for Stoudemire's inclusion, stating, “Amar'e Stoudemire's leadership, vision, and personal dedication to health makes him an invaluable voice on our Advisory Board. We share a belief that healthcare should be equitable, convenient, and informed; and that innovation should serve people, not the other way around.”

Future Plans for NOVODX

Looking ahead, NOVODX is focused on expanding the GoldN Reader’s test menu and is preparing for its market launch in the first quarter of 2026. The company is determined to transform the delivery and access of healthcare data, ensuring it supports informed health decisions.

By harnessing the power of technology, NOVODX aims to support early detection and accessible care through innovative, user-centered solutions. Their mission enables individuals to gain actionable health information critically needed in today’s health landscape.

About NOVODX Corporation

Founded on the principle that advanced healthcare should be easily accessible, NOVODX Corporation is committed to revolutionizing how patients receive at-home health testing. With a particular focus on women's health, fertility, infectious disease, oncology markers, and micronutrients, NOVODX’s platform aims to empower users with timely test results that are easy to interpret and securely share with healthcare providers, all within HIPAA guidelines. In this age of digital health, NOVODX is indeed at the forefront, bringing healthcare home.

Stay tuned for more exciting updates as NOVODX continues to innovate in the healthcare space.